AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Archives: News
How The Ethereum [ETH] Blockchain Is Powering The Next Generation Of Pharma Innovation
Ask the average person about the blockchain, and you’d be lucky if one in ten could tell you – even in vague terms – how the technology works, or even what it is. Buzzwords like Bitcoin will probably be uttered, but aside from cryptocurrencies, understanding of practical uses for blockchain technology has yet to hit …
How The Ethereum [ETH] Blockchain Is Powering The Next Generation Of Pharma Innovation Read More »
CEO and Founder Gunjan Bhardwaj, PhD On Driving Innovation and Ensuring Success
Gunjan Bhardwaj is the Founder and CEO of the Innoplexus group. He was earlier with the Boston Consulting Group and before that the leader of the global business performance think-tank of Ernst & Young and a manager in the German practice with a solution focus on strategy and innovation. He has led projects in strategy, …
CEO and Founder Gunjan Bhardwaj, PhD On Driving Innovation and Ensuring Success Read More »
Innoplexus launches new Blockchain platform for Pharma innovation
If your loved one was diagnosed with a potentially fatal illness, wouldn’t you want all the information possible to be available to those who could formulate a targeted treatment? Of course you would. And that’s precisely what inspired Gunjan Bhardwaj to found Innoplexus, with the aim of bringing more sophisticated machine learning and AI to …
Innoplexus launches new Blockchain platform for Pharma innovation Read More »
3 Reasons why Innoplexus is bringing Blockchain to Pharma
Don’t let the hype around blockchain fool you. Blockchain is only as useful as the solutions it provides. With all the excitement around blockchain as a means to simplify supply chains, streamline the financial sector, and cure the most persistent ills plaguing humanity, it’s tempting to forget that this talk has to give way to …
3 Reasons why Innoplexus is bringing Blockchain to Pharma Read More »
Innoplexus launches Blockchain platform to drive Pharma innovation
Researchers can now share unpublished data securely on the blockchain Global AI company Innoplexus launched today a groundbreaking blockchain platform to dramatically increase the amount of data available for drug research and discovery. This new platform—an update to Innoplexus’ flagship product iPlexus —is the first of its kind, and will allow researchers to upload and …
Innoplexus launches Blockchain platform to drive Pharma innovation Read More »
Beyond competition, Innoplexus believes in collaboration to nurture the ecosystem in a data-driven world
In the last five years, data science has continued to make rapid advances, particularly in the fields of machine learning and deep learning. Organisations now have troves of raw data which, when combined with insights garnered from powerful and sophisticated analytics tools, can improve operational performance and create new market opportunities. However, while the tools …
Gunjan Bhardwaj on “The American Dream”
Hosted by radio and TV personality Craig Sewing, ‘The American Dream’ is a national cable talk show that goes against the grain of all the negative stuff you keep seeing in the media. The American Dream is the only TV show that goes against the negative sensationalist style of journalism often seen in media. The …
When should pharma execs actually care about AI?
Artificial intelligence (AI) has recently garnered a lot of attention, and it is transforming the way pharma execs use their data. tech emergency, an AI market research company, recently revealed that interest in pharma-related AI articles has gone up by more than 10 times in the last year. What’s more, over 50% of healthcare industry …
When should pharma execs actually care about AI? Read More »
Consumer perceptions of pharma
Despite the millions of lives that are saved by pharmaceutical drugs each year, the pharmaceutical industry struggles against an enduring bad reputation. It’s not difficult to find statistics attesting to the frustration that many consumers feel about rising drug prices, corruption, and other real challenges that pharmaceutical companies face. But despite the negative public opinion, …